U.S. NHTSA Opens Full Probe Involving 2.2 M. Honda Vehicles
New York, March 28 (Jiji Press)--The U.S. National Highway Traffic Safety Administration said Friday that it has launched a full-scale probe regarding engine issues involving some 2.2 million Honda Motor Co. vehicles sold in the United States.
The investigation covers six models of the Japanese automaker, including the Pilot SUV of the 2016-2025 model years and the Odyssey minivan of the 2018-2025 model years, and may lead to a recall for free repairs.
(2025/03/29-12:44)
To read a full story, please click here to find out how to subscribe.
BUSINESS
-
04/03 22:25 U.S. Fund Urges Fuji Execs to Resign over Nakai Scandal -
04/02 23:39 (Update) Nintendo Switch 2 to Go on Sale June 5 - 04/02 23:20 Nintendo Switch 2 to Go on Sale June 5
- 04/02 22:12 Pasona to Display Beating "iPS Heart" at Osaka Expo
- 04/02 20:30 Jimoto Holdings Eyes Exit from Govt Control
- 04/02 19:55 Sumitomo Group's Osaka Expo Pavilion Unveiled to Press
- 04/02 17:21 Retailer Aeon to Sell Japan-U.S. Blended Rice
- 04/02 14:19 Japanese Makers Rushing to Mitigate Possible Nankai Trough Quake Damage
- 04/02 10:38 Japanese Automakers Post Higher U.S. Sales in 1st Quarter
- 04/02 09:31 Major Japanese Department Stores Post Lower Sales in March
- 04/02 09:06 Rapidus Launches Pilot Line for Advanced Chips
- 04/01 15:28 Jiji Press, Tokyo Shoseki Form Biz Tie-Up
- 03/31 23:13 Nissan to Cancel Investment in Renault EV Company
- 03/29 21:33 Sukiya to Temporarily Close Most Stores over Sanitary Issues
- 03/29 16:41 Rapidus to Launch Pilot Line for Advanced Chips Tues.
- 03/29 12:44 U.S. NHTSA Opens Full Probe Involving 2.2 M. Honda Vehicles
- 03/29 12:29 Many Japan Firms to Raise Starting Salaries: Jiji Survey
- 03/28 23:00 Japan Post Holdings CEO Masuda to Quit
- 03/28 20:52 Chiba Bank Acquires Stake in Chiba Kogyo Bank
- 03/28 19:37 Kobayashi Pharma Promotes Toyoda to CEO
- 03/28 17:50 SBI Shinsei Bank Repays 100 B. Yen to Japan Govt
- 03/28 17:36 Mitsui Sumitomo Insurance, Aioi Nissay Dowa to Merge
- 03/28 16:57 Kobayashi Pharma Shareholders Approve Board Nominees
